BERLIN, Aug 1 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab will invest 1.3 billion euros ($1.40 billion) in a new insulin production facility at its existing site in Frankfurt, where ...
LONDON, Nov 14 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of ...
In a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into a person with type 1 diabetes. The cells pumped out sugar-regulating insulin for months — without the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback